dan_philly said:If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.
This is exactly what I could not find anywhere else.
Adding the clinical framing, because it changes how the question reads. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.
Dr.LeslieOBGYN said:It is worth asking what the claim would look like if it were false.
This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDr.LeslieOBGYN said:It is worth asking what the claim would look like if it were false.
Coming at Dr.LeslieOBGYN’s question from a different direction. The pharmacokinetics explain nearly every practical question asked here. Albumin binding above 99% slows clearance enough to make weekly dosing possible; a terminal half-life near a week means four to five weeks to steady state and therefore a four-week titration interval; subcutaneous bioavailability around 89% means injection site barely matters. Those three facts answer most timing questions before they are asked.
One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.